At the news
? NEUTRALIMPACT 2/10 144 filed May 27, 2026 at 11:25 ET
Director Kevin K. Gordon filed a Form 144 notice of intent to sell 5,500 shares of Progyny (PGNY) at an estimated aggregate market value of $137,445. The shares were acquired via restricted stock vesting on May 22, 2026, and the sale is for compensation-related purposes. This is a routine insider sale by a director, not an executive officer, and represents a small fraction of the company's $2.0B market cap.
- Director Kevin K. Gordon filed Form 144 to sell 5,500 shares of PGNY common stock.
- Estimated aggregate market value of the proposed sale is $137,445.
- Shares were acquired via restricted stock vesting on May 22, 2026.
- The sale is for compensation-related purposes, not a discretionary open-market sale.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access